{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:36:08Z","timestamp":1793054168728,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zunyi Municipal Science and Technology Project","award":["ZSKHHZ-2024-218"],"award-info":[{"award-number":["ZSKHHZ-2024-218"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02473-5","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:36:43Z","timestamp":1784000203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive analysis of neutrophil extracellular traps-associated inflammatory genes for patients with idiopathic pulmonary fibrosis"],"prefix":"10.1007","volume":"301","author":[{"given":"Changhui","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuoxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"2473_CR1","doi-asserted-by":"publisher","unstructured":"Achaiah A, Rathnapala A et al (2022) Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis. BMJ open respiratory Res 9(1). https:\/\/doi.org\/10.1136\/bmjresp-2022-001202","DOI":"10.1136\/bmjresp-2022-001202"},{"issue":"3","key":"2473_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10456-024-09910-2","volume":"27","author":"M Ackermann","year":"2024","unstructured":"Ackermann M, Werlein C et al (2024) The role of vasculature and angiogenesis in respiratory diseases. Angiogenesis 27(3):293\u2013310. https:\/\/doi.org\/10.1007\/s10456-024-09910-2","journal-title":"Angiogenesis"},{"key":"2473_CR3","doi-asserted-by":"publisher","first-page":"109067","DOI":"10.1016\/j.biopha.2019.109067","volume":"117","author":"H Amano","year":"2019","unstructured":"Amano H, Mastui Y et al (2019) The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis. Biomed pharmacotherapy = Biomedecine pharmacotherapie 117:109067. https:\/\/doi.org\/10.1016\/j.biopha.2019.109067","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"2473_CR4","doi-asserted-by":"publisher","unstructured":"Arai T, Takimoto T et al (2023) Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. J Clin Med 12(23). https:\/\/doi.org\/10.3390\/jcm12237446","DOI":"10.3390\/jcm12237446"},{"issue":"15","key":"2473_CR5","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1042\/bcj20180266","volume":"475","author":"DP Byrne","year":"2018","unstructured":"Byrne DP, Li Y et al (2018) New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors. Biochem J 475(15):2435\u20132455. https:\/\/doi.org\/10.1042\/bcj20180266","journal-title":"Biochem J"},{"key":"2473_CR6","doi-asserted-by":"publisher","unstructured":"Crowley LE, Stockley RA et al (2024) Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives. Eur respiratory review: official J Eur Respiratory Soc 33(174). https:\/\/doi.org\/10.1183\/16000617.0139-2024","DOI":"10.1183\/16000617.0139-2024"},{"issue":"6","key":"2473_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/1060028020964451","volume":"55","author":"E Di Martino","year":"2021","unstructured":"Di Martino E, Provenzani A et al (2021) Systematic Review and Meta-analysis of Pirfenidone, Nintedanib, and Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis. Annals pharmacotherapy 55(6):723\u2013731. https:\/\/doi.org\/10.1177\/1060028020964451","journal-title":"Annals pharmacotherapy"},{"key":"2473_CR8","doi-asserted-by":"publisher","unstructured":"Eapen MS, Lu W et al (2020) Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Eur Respir J 56(4). https:\/\/doi.org\/10.1183\/13993003.03167-2020","DOI":"10.1183\/13993003.03167-2020"},{"key":"2473_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","volume":"147","author":"P Heukels","year":"2019","unstructured":"Heukels P, Moor CC et al (2019) Inflammation and immunity in IPF pathogenesis and treatment. Respir Med 147:79\u201391. https:\/\/doi.org\/10.1016\/j.rmed.2018.12.015","journal-title":"Respir Med"},{"key":"2473_CR10","doi-asserted-by":"publisher","unstructured":"Jo A, Kim DW (2023) Neutrophil Extracellular Traps in Airway Diseases: Pathological Roles and Therapeutic Implications. Int J Mol Sci 24(5). https:\/\/doi.org\/10.3390\/ijms24055034","DOI":"10.3390\/ijms24055034"},{"issue":"8","key":"2473_CR11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1164\/rccm.202212-2314LE","volume":"207","author":"JC Kamp","year":"2023","unstructured":"Kamp JC, Werlein C et al (2023) Novel Insight into Pulmonary Fibrosis and Long COVID. Am J Respir Crit Care Med 207(8):1105\u20131107. https:\/\/doi.org\/10.1164\/rccm.202212-2314LE","journal-title":"Am J Respir Crit Care Med"},{"key":"2473_CR12","doi-asserted-by":"publisher","unstructured":"Keir HR, Chalmers JD (2022) Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy. Eur respiratory review: official J Eur Respiratory Soc 31(163). https:\/\/doi.org\/10.1183\/16000617.0241-2021","DOI":"10.1183\/16000617.0241-2021"},{"key":"2473_CR13","doi-asserted-by":"publisher","unstructured":"King PT, Dousha L (2024) Neutrophil Extracellular Traps and Respiratory Disease. J Clin Med 13(8). https:\/\/doi.org\/10.3390\/jcm13082390","DOI":"10.3390\/jcm13082390"},{"key":"2473_CR14","doi-asserted-by":"publisher","unstructured":"Kolb P, Upagupta C et al (2020) The importance of interventional timing in the bleomycin model of pulmonary fibrosis. Eur Respir J 55(6). https:\/\/doi.org\/10.1183\/13993003.01105-2019","DOI":"10.1183\/13993003.01105-2019"},{"issue":"2","key":"2473_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s12325-021-02014-z","volume":"39","author":"B Langford","year":"2022","unstructured":"Langford B, Diamantopoulos A et al (2022) Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework. Adv therapy 39(2):1045\u20131054. https:\/\/doi.org\/10.1007\/s12325-021-02014-z","journal-title":"Adv therapy"},{"key":"2473_CR16","doi-asserted-by":"publisher","first-page":"963054","DOI":"10.3389\/fphar.2022.963054","volume":"13","author":"H Ma","year":"2022","unstructured":"Ma H, Wu X et al (2022a) Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis. Front Pharmacol 13:963054. https:\/\/doi.org\/10.3389\/fphar.2022.963054","journal-title":"Front Pharmacol"},{"issue":"22","key":"2473_CR17","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.26355\/eurrev_202211_30377","volume":"26","author":"YJ Ma","year":"2022","unstructured":"Ma YJ, Zhang Q et al (2022b) The efficacy and safety of pirfenidone in the treatment of HPS-related pulmonary fibrosis and Idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 26(22):8411\u20138424. https:\/\/doi.org\/10.26355\/eurrev_202211_30377","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2473_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","volume":"22","author":"TM Maher","year":"2021","unstructured":"Maher TM, Bendstrup E et al (2021) Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res 22(1):197. https:\/\/doi.org\/10.1186\/s12931-021-01791-z","journal-title":"Respir Res"},{"issue":"3","key":"2473_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","volume":"40","author":"A Moeller","year":"2008","unstructured":"Moeller A, Ask K et al (2008) The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40(3):362\u2013382. https:\/\/doi.org\/10.1016\/j.biocel.2007.08.011","journal-title":"Int J Biochem Cell Biol"},{"key":"2473_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","volume":"17","author":"BJ Moss","year":"2022","unstructured":"Moss BJ, Ryter SW et al (2022) Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. Annu Rev Pathol 17:515\u2013546. https:\/\/doi.org\/10.1146\/annurev-pathol-042320-030240","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"2473_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.33549\/physiolres.935322","volume":"73","author":"J Muri","year":"2024","unstructured":"Muri J, Durcov\u00e1 B et al (2024) Idiopathic Pulmonary Fibrosis: Review of Current Knowledge. Physiol Res 73(4):487\u2013497. https:\/\/doi.org\/10.33549\/physiolres.935322","journal-title":"Physiol Res"},{"key":"2473_CR22","doi-asserted-by":"publisher","first-page":"108562","DOI":"10.1016\/j.pharmthera.2023.108562","volume":"252","author":"SE Mutsaers","year":"2023","unstructured":"Mutsaers SE, Miles T et al (2023) Emerging role of immune cells as drivers of pulmonary fibrosis. Pharmacol Ther 252:108562. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108562","journal-title":"Pharmacol Ther"},{"key":"2473_CR23","doi-asserted-by":"publisher","unstructured":"Ngamsri KC, M\u00fcller A et al (2017) The Pivotal Role of CXCR7 in Stabilization of the Pulmonary Epithelial Barrier in Acute Pulmonary Inflammation. Journal of immunology (Baltimore, Md: 1950) 198(6):2403\u20132413. https:\/\/doi.org\/10.4049\/jimmunol.1601682","DOI":"10.4049\/jimmunol.1601682"},{"key":"2473_CR24","doi-asserted-by":"publisher","first-page":"663303","DOI":"10.3389\/fimmu.2021.663303","volume":"12","author":"L Pandolfi","year":"2021","unstructured":"Pandolfi L, Bozzini S et al (2021) Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis. Front Immunol 12:663303. https:\/\/doi.org\/10.3389\/fimmu.2021.663303","journal-title":"Front Immunol"},{"issue":"8","key":"2473_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1021\/acsptsci.2c00050","volume":"5","author":"Z Peng","year":"2022","unstructured":"Peng Z, Konai MM et al (2022) MMP-1 and ADAM10 as Targets for Therapeutic Intervention in Idiopathic Pulmonary Fibrosis. ACS Pharmacol translational Sci 5(8):548\u2013554. https:\/\/doi.org\/10.1021\/acsptsci.2c00050","journal-title":"ACS Pharmacol translational Sci"},{"key":"2473_CR26","doi-asserted-by":"publisher","unstructured":"Reccardini N, Chernovsky M et al (2024) Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant. Pharmaceuticals (Basel Switzerland) 17(7). https:\/\/doi.org\/10.3390\/ph17070930","DOI":"10.3390\/ph17070930"},{"issue":"10082","key":"2473_CR27","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/s0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR et al (2017) Idiopathic pulmonary fibrosis. Lancet (London England) 389(10082):1941\u20131952. https:\/\/doi.org\/10.1016\/s0140-6736(17)30866-8","journal-title":"Lancet (London England)"},{"issue":"4","key":"2473_CR28","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1371\/journal.pmed.0050093","volume":"5","author":"IO Rosas","year":"2008","unstructured":"Rosas IO, Richards TJ et al (2008) MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 5(4):e93. https:\/\/doi.org\/10.1371\/journal.pmed.0050093","journal-title":"PLoS Med"},{"issue":"43","key":"2473_CR29","doi-asserted-by":"publisher","first-page":"11251","DOI":"10.1021\/bi800965m","volume":"47","author":"C Seibert","year":"2008","unstructured":"Seibert C, Veldkamp CT et al (2008) Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases. Biochemistry 47(43):11251\u201311262. https:\/\/doi.org\/10.1021\/bi800965m","journal-title":"Biochemistry"},{"key":"2473_CR30","doi-asserted-by":"publisher","unstructured":"Shenderov K, Collins SL et al (2021) Immune dysregulation as a driver of idiopathic pulmonary fibrosis. J Clin Investig 131(2). https:\/\/doi.org\/10.1172\/jci143226","DOI":"10.1172\/jci143226"},{"issue":"9\u201310","key":"2473_CR31","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10495-023-01868-8","volume":"28","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wang Y et al (2023) Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis: Int J Program cell death 28(9\u201310):1423\u20131435. https:\/\/doi.org\/10.1007\/s10495-023-01868-8","journal-title":"Apoptosis: Int J Program cell death"},{"issue":"16","key":"2473_CR32","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC et al (2021) Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA 326(16):1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236","journal-title":"JAMA"},{"issue":"8","key":"2473_CR33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/s2213-2600(20)30222-8","volume":"8","author":"P Spagnolo","year":"2020","unstructured":"Spagnolo P, Balestro E et al (2020) Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respiratory Med 8(8):750\u2013752. https:\/\/doi.org\/10.1016\/s2213-2600(20)30222-8","journal-title":"Lancet Respiratory Med"},{"issue":"6","key":"2473_CR34","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1165\/rcmb.2019-0433OC","volume":"63","author":"M Suzuki","year":"2020","unstructured":"Suzuki M, Ikari J et al (2020) PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung. Am J Respir Cell Mol Biol 63(6):806\u2013818. https:\/\/doi.org\/10.1165\/rcmb.2019-0433OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"2473_CR35","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1183\/09031936.00127011","volume":"40","author":"A Takemasa","year":"2012","unstructured":"Takemasa A, Ishii Y et al (2012) A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice. Eur Respir J 40(6):1475\u20131482. https:\/\/doi.org\/10.1183\/09031936.00127011","journal-title":"Eur Respir J"},{"key":"2473_CR36","doi-asserted-by":"publisher","first-page":"112269","DOI":"10.1016\/j.intimp.2024.112269","volume":"135","author":"P Tiwari","year":"2024","unstructured":"Tiwari P, Verma S et al (2024) Immune cells crosstalk Pathways, and metabolic alterations in Idiopathic pulmonary fibrosis. Int Immunopharmacol 135:112269. https:\/\/doi.org\/10.1016\/j.intimp.2024.112269","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"2473_CR37","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.7150\/ijms.73305","volume":"19","author":"E Wang","year":"2022","unstructured":"Wang E, Wang Y et al (2022) Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis. Int J Med Sci 19(9):1417\u20131429. https:\/\/doi.org\/10.7150\/ijms.73305","journal-title":"Int J Med Sci"},{"key":"2473_CR38","doi-asserted-by":"publisher","unstructured":"Wang Y, Du C et al (2024) Composition and Function of Neutrophil Extracellular Traps. Biomolecules 14(4). https:\/\/doi.org\/10.3390\/biom14040416","DOI":"10.3390\/biom14040416"},{"issue":"16","key":"2473_CR39","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1038\/onc.2015.274","volume":"35","author":"YC Wu","year":"2016","unstructured":"Wu YC, Tang SJ et al (2016) CXCR7 mediates TGF\u03b21-promoted EMT and tumor-initiating features in lung cancer. Oncogene 35(16):2123\u20132132. https:\/\/doi.org\/10.1038\/onc.2015.274","journal-title":"Oncogene"},{"key":"2473_CR40","doi-asserted-by":"publisher","first-page":"115124","DOI":"10.1016\/j.biopha.2023.115124","volume":"165","author":"K Xiao","year":"2023","unstructured":"Xiao K, Liu C et al (2023) Umbilical cord mesenchymal stem cells overexpressing CXCR7 facilitate treatment of ARDS-associated pulmonary fibrosis via inhibition of Notch\/Jag1 mediated by the Wnt\/\u03b2-catenin pathway. Biomed pharmacotherapy = Biomedecine pharmacotherapie 165:115124. https:\/\/doi.org\/10.1016\/j.biopha.2023.115124","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"2473_CR41","doi-asserted-by":"publisher","first-page":"1134521","DOI":"10.3389\/fimmu.2023.1134521","volume":"14","author":"H Xin","year":"2023","unstructured":"Xin H, Lai Q et al (2023) Noninvasive evaluation of neutrophil extracellular traps signature predicts clinical outcomes and immunotherapy response in hepatocellular carcinoma. Front Immunol 14:1134521. https:\/\/doi.org\/10.3389\/fimmu.2023.1134521","journal-title":"Front Immunol"},{"key":"2473_CR42","doi-asserted-by":"publisher","unstructured":"Xu Y, Lan P et al (2023) The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis. Med (Kaunas Lithuania) 59(11). https:\/\/doi.org\/10.3390\/medicina59111984","DOI":"10.3390\/medicina59111984"},{"key":"2473_CR43","doi-asserted-by":"publisher","first-page":"1331000","DOI":"10.3389\/fmed.2023.1331000","volume":"10","author":"N Xuan","year":"2023","unstructured":"Xuan N, Zhao J et al (2023) Neutrophil extracellular traps and their implications in airway inflammatory diseases. Front Med 10:1331000. https:\/\/doi.org\/10.3389\/fmed.2023.1331000","journal-title":"Front Med"},{"issue":"1","key":"2473_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12950-023-00329-y","volume":"20","author":"S Yan","year":"2023","unstructured":"Yan S, Li M et al (2023) Neutrophil extracellular traps and pulmonary fibrosis: an update. J Inflamm (London England) 20(1):2. https:\/\/doi.org\/10.1186\/s12950-023-00329-y","journal-title":"J Inflamm (London England)"},{"key":"2473_CR45","doi-asserted-by":"publisher","first-page":"113714","DOI":"10.1016\/j.ejmech.2021.113714","volume":"224","author":"L Yue","year":"2021","unstructured":"Yue L, Shi Y et al (2021) Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectives. Eur J Med Chem 224:113714. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113714","journal-title":"Eur J Med Chem"},{"key":"2473_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2024.05.011","volume":"272","author":"TL Zhang","year":"2024","unstructured":"Zhang TL, Chen WK et al (2024) Single-cell RNA sequencing reveals the MIF\/ACKR3 receptor-ligand interaction between neutrophils and nucleus pulposus cells in intervertebral disc degeneration. Translational research: J Lab Clin Med 272:1\u201318. https:\/\/doi.org\/10.1016\/j.trsl.2024.05.011","journal-title":"Translational research: J Lab Clin Med"},{"key":"2473_CR47","doi-asserted-by":"publisher","first-page":"1109903","DOI":"10.3389\/fgene.2022.1109903","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Wang C et al (2022) A prognostic model based on clusters of molecules related to epithelial-mesenchymal transition for idiopathic pulmonary fibrosis. Front Genet 13:1109903. https:\/\/doi.org\/10.3389\/fgene.2022.1109903","journal-title":"Front Genet"}],"updated-by":[{"DOI":"10.1007\/s00438-026-02521-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000}}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02473-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02473-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02473-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:02:06Z","timestamp":1793052126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02473-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2473"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02473-5","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to update the figure 8 in the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00438-026-02521-0","URL":"https:\/\/doi.org\/10.1007\/s00438-026-02521-0","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Affiliated Hospital of Zunyi Medical University approved the ethical standards under which all animal experiments were performed (approval no: zyfy-an-2023-0186).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"153"}}